News

Subclinical hyperthyroidism linked to higher fracture risk

Posted on: 26/05/2015 - 17:27

Individuals with subclinical hyperthyroidism are at increased risk of hip and other fractures, according to the authors of a...

Field of Interest: Geriatrics

Type: News Item

DDW: Antibiotic rifaximin eases functional dyspepsia symptoms

Posted on: 22/05/2015 - 19:36

WASHINGTON – Two weeks of antibiotic therapy with rifaximin provided relief from functional dyspepsia symptoms in a phase III...

Field of Interest: Gastroentero...

Type: News Item

BSR: Multiple benefits seen with intensive psoriatic arthritis therapy

Posted on: 22/05/2015 - 16:48

MANCHESTER, U.K. – Multiple joint and skin benefits can be achieved by intensively treating patients with psoriatic arthritis until they achieve a set of minimal disease activity criteria, an expert...

Field of Interest: Rheumatology

Type: News Item

BSR: Multiple benefits seen with intensive psoriatic arthritis therapy

Posted on: 22/05/2015 - 16:48

Field of Interest: Dermatology

Type: News Item

FDA warns of possible dosing errors with Zerbaxa

Posted on: 21/05/2015 - 20:30

Confusion about the strength of the antibacterial drug Zerbaxa could potentially lead to dosage errors, the Food and Drug Administration cautioned in a May 20 <a...

Field of Interest: Gastroentero...

Type: News Item

DXA screening: You’re doing it wrong

Posted on: 21/05/2015 - 17:35

Dual-energy x-ray absorptiometry to screen for osteoporosis is both underused in women who meet the U.S. Preventive Services Task Force criteria for screening, and overused in low-risk younger women,...

Field of Interest: Geriatrics

Type: News Item

DXA screening: You’re doing it wrong

Posted on: 21/05/2015 - 17:35

Field of Interest: Rheumatology

Type: News Item

DXA screening: You’re doing it wrong

Posted on: 21/05/2015 - 17:35

Field of Interest: Pulmonology

Type: News Item

VIDEO: Is it IBS? Blood test may offer conclusive answer

Posted on: 20/05/2015 - 22:18

WASHINGTON – A new blood test could conclusively determine if a patient with chronic diarrhea has diarrhea-predominant irritable bowel syndrome (D-IBS). The IBSchek blood test detects the presence...

Field of Interest: Gastroentero...

Type: News Item

DDW: Ozanimod active in moderate-severe UC, without cardiac signal in TOUCHSTONE trial

Posted on: 20/05/2015 - 16:36

WASHINGTON– The oral S1P receptor modulator ozanimod is clinically active and well tolerated in patients with moderate to severe ulcerative colitis (UC), phase II study results show. Importantly, no...

Field of Interest: Gastroentero...

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters